Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry

We present data showing improvement in response on treatment and in survival in Swedish MM patients since the forming of the national Swedish Myeloma Registry (SMR).
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research